Last updates: |
|
EU Promotes Citizen's Health
|
EU and Diseases and Health Threats
The EU wants a new health security framework suited to today's and tomorrow's health challenges. The post-coronavirus calls for an important role of EU agencies in coordinating preparedness and response measures
|
EU Medical Devices
Europe is at the forefront and produces more than 500,000 medical devices. The EU has set up a legal and regulatory framework to facilitate the growth of this sector and to better protect citizens.
|
Pharmaceuticals in Europe
To ensure high standards of quality and safety, the EU has put in place a comprehensive legal framework. Medicines can now be authorized at EU level, or at national level. There are special rules for the authorization of pediatric medicines, orphan medicines, traditional herbal medicines, vaccines and clinical trials. A EU pharmacovigilance system is in place. At EU level, EMA, the European Medicines Agency established in 1995, coordinates the national authorities and gives centralised authorisations.
|
Biocides and Rules in Europe
The EU provides an EU-wide framework and harmonized rules across EU countries to ensure that risks are properly assessed before biocidal products are placed on the market. The European Chemicals Agency (ECHA) provides technical and scientific assistance to support the European Commission and EU countries in carrying out the different processes required by the regulation.
|
EU and Endocrine DisruptorsEU is preparing a strategy on endocrine disruptors and during next months will adopt measures to protect citizens.
|
Substances of human originDespite the benefits of some Substances of Human Origin (SoHO), their use presents risks, in particular the transmission of diseases. The European Commission helps address these risks through its mandate to set high standards of quality and safety of SoHO.
|